Ornella Strada
About Ornella Strada
Ornella Strada is an Immuno Oncology Senior Medical Science Manager at Bristol-Myers Squibb with over 16 years of experience in the pharmaceutical industry.
Company
Ornella Strada is currently employed by Bristol-Myers Squibb, a globally recognized pharmaceutical company. She serves as the Immuno Oncology Senior Medical Science Manager. Bristol-Myers Squibb is based in New Jersey, United States, and focuses on biopharmaceuticals aimed at addressing serious diseases. Ornella has been with the company for over 16 years, starting in May 2007.
Title
Ornella Strada holds the position of Immuno Oncology Senior Medical Science Manager at Bristol-Myers Squibb. In this role, she oversees medical science initiatives within the Immuno Oncology sector. Her responsibilities likely include managing medical affairs, conducting research, and collaborating with other experts in the field.
Past Experience
Before joining Bristol-Myers Squibb, Ornella Strada worked at AstraZeneca in Cambridge, United Kingdom. She served in the Medical Affairs department from 2005 to 2007. Prior to that, she was the Neurologist Advisor for the CNS (Central Nervous System) area at Dompé Biotec in Italy from 1996 to 1999. These roles provided her with extensive experience in medical affairs and neurology.
Education and Expertise
Ornella Strada earned her Doctor of Medicine and Doctorates from Università Degli Studi Di Milano. Her academic background and training provided a strong foundation for her work in the pharmaceutical industry. She specializes in Immuno Oncology, Neurology, Psychiatry, and Neuroscience. Her experience extends to neurobiological research focused on Parkinson's disease and Alzheimer's disease.
Publications and Research
Ornella Strada has authored multiple peer-reviewed journal publications in the fields of neurology and immuno-oncology. Her research contributions have focused particularly on neurobiological studies related to diseases such as Parkinson's and Alzheimer's. This body of work highlights her significant contributions to medical science and the pharmaceutical industry.